Interpace Biosciences
IDXG
#10519
Rank
C$50.95 M
Marketcap
C$8.63
Share price
-3.20%
Change (1 day)
527.62%
Change (1 year)

Earnings for Interpace Biosciences (IDXG)

Earnings in 2026 (TTM): C$5.59 Million

According to Interpace Biosciences's latest financial reports the company's current earnings are C$36.14 Million. In 2025 the company made an earning of C$5.62 Million a decrease over its 2024 earnings that were of C$12.3 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Interpace Biosciences from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$5.59 M-0.53%
2025 C$5.62 M-54.26%
2024 C$12.3 M303.23%
2023 C$3.05 M-144.63%
2022 -C$6.84 Million-60.98%
2021 -C$17.52 Million-52.04%
2020 -C$36.53 Million-2.68%
2019 -C$37.54 Million121.84%
2018 -C$16.92 Million-6.07%
2017 -C$18.02 Million96.31%
2016 -C$9.18 Million-86.7%
2015 -C$69.01 Million382.48%
2014 -C$14.31 Million134.35%
2013 -C$6.11 Million323.89%
2012 -C$1.44 Million-79.01%
2011 -C$6.86 Million29.08%
2010 -C$5.32 Million-82.57%
2009 -C$30.49 Million-39.28%
2008 -C$50.22 Million146.45%
2007 -C$20.38 Million-269.18%
2006 C$12.04 M-131.08%
2005 -C$38.75 Million-177.16%
2004 C$50.21 M78.33%
2003 C$28.15 M-142.02%
2002 -C$67.01 Million-469.63%
2001 C$18.12 M-68.92%
2000 C$58.32 M140.45%
1999 C$24.25 M
1997 C$3.42 M